{"title":"Establishment of a feasible surgical strategy for aortoesophageal fistula","authors":"Katsuhiro Yamanaka MD, PhD, Kenji Okada MD, PhD, Kazunori Sakaguchi MD, Tasuku Okada MD, Hironaga Shiraki MD, Ryo Kawabata MD, Jun Karaki MD, Yasufumi Koterazawa MD, PhD, Noriko Oyama MD, PhD, Soichiro Henmi MD, PhD, Hironobu Goto MD, PhD, Hiroaki Takahashi MD, PhD, Yutaka Okita MD, PhD","doi":"10.1016/j.xjtc.2026.102502","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Aortoesophageal fistula (AEF) represents one of the most challenging and devastating complications in aortic surgery. This study aimed to evaluate the feasibility, technical considerations, and clinical outcomes of our standardized multidisciplinary strategy for AEF, which has been consistently applied since 2008.</div></div><div><h3>Methods</h3><div>This retrospective study included 21 patients with AEF who underwent open surgery from January 2008 to September 2025. The primary end point was freedom from infection-related death, reflecting the central role of infection control in AEF management. Secondary end points included hospital mortality, overall survival, and the esophageal reconstruction rate.</div></div><div><h3>Results</h3><div>The mean age was 69.3 ± 11.2 years. Hospital mortality after open surgery was 26.9%. The 10-year overall survival and freedom from infection-related death were 38.4 ± 13.2% and 89.7 ± 6.8%, respectively. After implementation of our current standardized strategy in 2008, no recurrent infections were observed, and 10 patients successfully completed reconstruction.</div></div><div><h3>Conclusions</h3><div>Although hospital mortality remains substantial, long-term outcomes were favorable. The current multidisciplinary surgical strategy was associated with improved infection-related outcomes, with no recurrent infections observed.</div></div>","PeriodicalId":53413,"journal":{"name":"JTCVS Techniques","volume":"39 ","pages":"Article 102502"},"PeriodicalIF":2.4000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JTCVS Techniques","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666250726003093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
Aortoesophageal fistula (AEF) represents one of the most challenging and devastating complications in aortic surgery. This study aimed to evaluate the feasibility, technical considerations, and clinical outcomes of our standardized multidisciplinary strategy for AEF, which has been consistently applied since 2008.
Methods
This retrospective study included 21 patients with AEF who underwent open surgery from January 2008 to September 2025. The primary end point was freedom from infection-related death, reflecting the central role of infection control in AEF management. Secondary end points included hospital mortality, overall survival, and the esophageal reconstruction rate.
Results
The mean age was 69.3 ± 11.2 years. Hospital mortality after open surgery was 26.9%. The 10-year overall survival and freedom from infection-related death were 38.4 ± 13.2% and 89.7 ± 6.8%, respectively. After implementation of our current standardized strategy in 2008, no recurrent infections were observed, and 10 patients successfully completed reconstruction.
Conclusions
Although hospital mortality remains substantial, long-term outcomes were favorable. The current multidisciplinary surgical strategy was associated with improved infection-related outcomes, with no recurrent infections observed.